argenx SE (ARGX)
1011.29
-28.49
(-2.74%)
USD |
NASDAQ |
Aug 24, 16:00
1011.29
0.00 (0.00%)
After-Hours: 20:00
argenx Market Cap : 62.58B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 64.35B |
| August 20, 2026 | 64.24B |
| August 19, 2026 | 63.92B |
| August 18, 2026 | 61.45B |
| August 17, 2026 | 61.13B |
| August 14, 2026 | 52.68B |
| August 13, 2026 | 53.03B |
| August 12, 2026 | 54.21B |
| August 11, 2026 | 53.51B |
| August 10, 2026 | 53.60B |
| August 07, 2026 | 53.53B |
| August 06, 2026 | 54.17B |
| August 05, 2026 | 53.71B |
| August 04, 2026 | 52.26B |
| August 03, 2026 | 51.41B |
| July 31, 2026 | 52.84B |
| July 30, 2026 | 54.00B |
| July 29, 2026 | 54.62B |
| July 28, 2026 | 53.98B |
| July 27, 2026 | 55.00B |
| July 24, 2026 | 56.82B |
| July 23, 2026 | 57.22B |
| July 22, 2026 | 52.71B |
| July 21, 2026 | 54.13B |
| July 20, 2026 | 52.37B |
| Date | Value |
|---|---|
| July 17, 2026 | 53.25B |
| July 16, 2026 | 53.09B |
| July 15, 2026 | 53.40B |
| July 14, 2026 | 53.18B |
| July 13, 2026 | 54.23B |
| July 10, 2026 | 54.31B |
| July 09, 2026 | 56.28B |
| July 08, 2026 | 56.64B |
| July 07, 2026 | 56.93B |
| July 06, 2026 | 56.73B |
| July 02, 2026 | 58.15B |
| July 01, 2026 | 56.28B |
| June 30, 2026 | 57.41B |
| June 29, 2026 | 56.47B |
| June 26, 2026 | 54.90B |
| June 25, 2026 | 54.99B |
| June 24, 2026 | 52.76B |
| June 23, 2026 | 52.81B |
| June 22, 2026 | 55.93B |
| June 18, 2026 | 54.32B |
| June 17, 2026 | 55.22B |
| June 16, 2026 | 54.36B |
| June 15, 2026 | 54.72B |
| June 12, 2026 | 55.29B |
| June 11, 2026 | 55.63B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Autolus Therapeutics Plc | 624.15M |
| Akari Therapeutics Plc | 13.16M |
| Forte Biosciences, Inc. | 1.576B |
| Evaxion AS | 28.02M |
| Grifols SA | 2.062B |
Market Cap Related Metrics
| PE Ratio | 38.54 |
| PS Ratio | 12.65 |
| Price to Free Cash Flow | 60.62 |
| Price | 1011.29 |
| Earnings Yield | 2.59% |
| Operating PE Ratio | 43.87 |
| Normalized PE Ratio | 38.54 |